(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 5.91% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.12%.
Radnet's revenue in 2025 is $1,907,872,000.On average, 3 Wall Street analysts forecast RDNT's revenue for 2025 to be $152,177,351,842, with the lowest RDNT revenue forecast at $151,832,306,388, and the highest RDNT revenue forecast at $152,424,560,065. On average, 2 Wall Street analysts forecast RDNT's revenue for 2026 to be $164,598,834,359, with the lowest RDNT revenue forecast at $163,523,547,812, and the highest RDNT revenue forecast at $165,674,120,906.
In 2027, RDNT is forecast to generate $177,055,390,600 in revenue, with the lowest revenue forecast at $177,055,390,600 and the highest revenue forecast at $177,055,390,600.